# US 2023/0406812 A1 · Novel aminoaromatic compound or pharmaceutically acceptable salt thereof, and pharmaceutical composition for preventing or treating neurodegenerative diseases comprising same as active ingredient

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0406812 A1
- Document ID: US20230406812A1
- Status: Published application
- Kind: A1
- Application number: 18/036,847
- Filed: 2021-11-12
- Published: 2023-12-21
- Earliest claimed: 2020-11-13
- Assignees: Institute for Basic Science; Korea Institute of Science and Technology
- Applicants: Institute for Basic Science; Korea Institute of Science and Technology
- Inventors: Chang Jun LEE; Heejung CHUN; Woojin WON; Ki Duk PARK; Jong Hyun PARK; Ae Nim PAE; Ji Won CHOI; Elijah LEE; Sun Jun PARK; Hyeon Jeong KIM; Yoowon KIM; Byung Eun KIM; Siwon KIM
- Web page: https://patentgrep.com/patent/US20230406812A1

## CPC

- C07C 211/53: having the nitrogen atom of at least one of the amino groups further bound to a hydrocarbon radical substituted by amino groups
- A23L 33/10: using additives (addition of substantially indigestible substances A23L33/21)
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- C07C 211/50: with at least two amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C 217/60: linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention provides a novel aminoaromatic compound or a pharmaceutically acceptable salt thereof, a pharmaceutical composition that is for preventing or treating neurodegenerative diseases and comprises same as an active ingredient, and a health functional food composition for preventing or ameliorating neurodegenerative diseases.

## Claims

### Claim 1

An aminoaromatic compound represented by the following Chemical Formula 1 or a pharmaceutically acceptable salt thereof:
wherein
Ar is C6-C20 arylene, and the arylene of Ar may be further substituted by one or more selected from C1-C10 alkyl, C1-C10 alkoxy, amino, mono- or di-C1-C10 alkylamino, haloC1-C10 alkyl, and haloC1-C10 alkoxy and hydroxy;
R1 and R2 are independently of each other hydrogen or C1-C10 alkyl;
R3 is halogen, C1-C10 alkoxy, haloC1-C10 alkyl, or haloC1-C10 alkoxy; and
n is an integer of 1 or 2;
provided that R3 is halogen, n is an integer of 1.

### Claim 2 (depends on 1)

The aminoaromatic compound or the pharmaceutically acceptable salt thereof of claim 1, wherein Ar is phenylene or biphenylene; and may be further substituted with one or more selected from C1-C7 alkyl, C1-C7 alkoxy, amino, and hydroxy.

### Claim 3 (depends on 1)

The aminoaromatic compound or the pharmaceutically acceptable salt thereof of claim 1, wherein the aminoaromatic compound is represented by the following Chemical Formula 2:
wherein
R1 and R2 are independently of each other hydrogen or C1-C7 alkyl;
Hal is halogen;
R′ is C1-C7 alkyl, C1-C7 alkoxy, amino, or hydroxy; and
a is an integer of 0 to 4.

### Claim 4 (depends on 1)

The aminoaromatic compound or the pharmaceutically acceptable salt thereof of claim 1, wherein the aminoaromatic compound is represented by the following Chemical Formula 3:
wherein
R1 and R2 are independently of each other hydrogen or C1-C7 alkyl;
R3 is C1-C7 alkoxy or haloC1-C7 alkyl;
R′ is C1-C7 alkyl, C1-C7 alkoxy, amino, or hydroxy;
a is an integer of 0 to 4; and
n is an integer of 1 or 2.

### Claim 5 (depends on 3)

The aminoaromatic compound or the pharmaceutically acceptable salt thereof of claim 3, wherein R1 and R2 are independently of each other hydrogen or C1-C4 alkyl; Hal is halogen; and a is an integer of 0.

### Claim 6 (depends on 4)

The aminoaromatic compound or the pharmaceutically acceptable salt thereof of claim 4, wherein R1 and R2 are independently of each other hydrogen or C1-C4 alkyl; R3 is C1-C4 alkoxy or haloC1-C4 alkyl; a is an integer of 0; and n is an integer of 1 or 2.

### Claim 7 (depends on 3)

The aminoaromatic compound or the pharmaceutically acceptable salt thereof of claim 3, wherein the aminoaromatic compound is any one selected from the following compound group:

### Claim 8 (depends on 4)

The aminoaromatic compound or the pharmaceutically acceptable salt thereof of claim 4, wherein the aminoaromatic compound is any one selected from the following compound group:

### Claim 9 (depends on 1)

The aminoaromatic compound or the pharmaceutically acceptable salt thereof of claim 1, wherein the pharmaceutically acceptable salt is a hydrochloride.

### Claim 10 (depends on 1)

A pharmaceutical composition for treating or preventing neurodegenerative diseases comprising the aminoaromatic compound or the pharmaceutically acceptable salt of claim 1 as an effective component.

### Claim 11 (depends on 10)

The pharmaceutical composition of claim 10, further comprising an excipient and a carrier.

### Claim 12 (depends on 10)

The pharmaceutical composition of claim 10, wherein the neurodegenerative disease is dementia, Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease, Lou Gehrig's disease (ALS), post-traumatic stress disorder (trauma), multiple sclerosis (MS), cerebral ischemia disease, or amyotrophic lateral sclerosis.

### Claim 13 (depends on 10)

A method of preventing or treating neurodegenerative diseases comprising administrating the pharmaceutical composition of claim 10 to an individual which has or is at risk of the neurodegenerative disease.

### Claim 14 (depends on 1)

A health functional food composition for preventing or ameliorating neurodegenerative diseases comprising the aminoaromatic compound of claim 1 or a sitologically acceptable salt thereof as an effective component.
